Minimally invasive image-guided therapies for hepatocellular carcinoma

Journal of Clinical Gastroenterology

Volumn 35, Issue 5 SUPPL., 2002, Pages

  Goldberg, S Nahum ^a   Ahmed, Muneeb ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Laser photocoagulation; Microwave; Minimally invasive therapy; Percutaneous ethanol instillation; Radiofrequency; Tumor ablation

Indexed keywords

ACETIC ACID; ALCOHOL; ALPHA FETOPROTEIN; DOXORUBICIN; IODINATED POPPYSEED OIL; ZINOSTATIN;

ABDOMINAL PAIN; ANOREXIA; ARTIFICIAL EMBOLISM; CANCER PALLIATIVE THERAPY; CATHETER ABLATION; CONFERENCE PAPER; DISORIENTATION; FATIGUE; FEVER; HUMAN; LIVER CELL CARCINOMA; LOW LEVEL LASER THERAPY; MICROWAVE IRRADIATION; MINIMALLY INVASIVE SURGERY; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; ANTI-INFECTIVE AGENTS, LOCAL; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; CRYOSURGERY; DOXORUBICIN; ETHANOL; HUMANS; HYPERTHERMIA, INDUCED; LASERS; LIVER NEOPLASMS;

EID: 0036841182     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200211002-00008     Document Type: Conference Paper

References (175)

1. Goldberg SN, Dupuy DE. Image-guided radiofrequency tumor ablation: Challenges and opportunities - Part I. J Vasc Interv Radiol 2001;12:1021-32.
2. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am J Radiol 2000;174:323-31.
3. Dodd GD 3rd, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignant hepatic tumors: At the threshold of a major breakthrough. Radiographics 2000;20:9-27.
4. Colella G, Bottelli R, De Carlis L, et al. Hepatocellular carcinoma: Comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int 1998:11(Suppl 1):S193-96.
5. Survey and Follow-Up Study of Primary Liver Cancer in Japan: Report 14. Liver Cancer Study Group of Japan 2000:Kyoto, Shinko-insatsu
6. Ahmed M, Goldberg SN. Thermal ablation therapy for hepatocellular carcinoma. J Vasc Interv Radiol 2002: In press.
7. Hussain SA, Ferry DR, El-Gazzaz G, et al. Hepatocellular carcinoma. Ann Oncol 2001;12:161-72.
8. Livraghi T. Guidelines for treatment of liver cancer. Eur J Ultrasound 2001; 13:167-76.
9. Kruskal JB, Oliver B, Huertas JC, et al. Dynamic intrahepatic flow and cellular alterations during radiofrequency ablation of liver tumors in mice. J Vasc Interv Radiol 2001;12:1193-201.
10. Matsuo N, Uchida H, Nishimine K, et al. Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: Antitumor effect and influence on normal tissue. J Vasc Interv Radiol 1993;4:543-9.
11. A comparison of lipiodol chemoembolization and conservative treatment of unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. N Engl J Med 1995;332:1256-61.
12. Rajan DK, Soulen MC, Clark TW, et al. Sarcomas metastatic to the liver: Response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization. J Vasc Interv Radiol 2001;12:187-93.
13. Solomon B, Soulen MC, Baum RA, et al. Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol: Prospective evaluation of response and survival in a U.S. population. J Vasc Interv Radiol 1999;10:793-8.
14. Soulen MC, Chemoembolization of hepatic malignancies. Oncology (Huntingt) 1994;8:77-84.
15. Takayasu K, Muramatsu Y, Maeda T, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: Analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 2001;176:681-8.
16. Uchida H, Matsuo N, Sakaguchi H, et al. Chemoembolization therapy in small hepatocellular carcinoma. Gan To Kagaku Ryoho 1996;23:840-8.
17. Huang YH, Wu JC, Chau GY, et al. Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: An analysis of survival in 419 patients. Eur J Gastroenterol Hepatol 1999;11:315-21.
18. Zangos S, Gille T, Eichler K, et al. Transarterial chemoembolization in hepatocellular carcinomas: Technique, indications, results. Radiologe 2001;41:906-14.
19. Poyanli A, Rozanes I, Acunas B, et al. Palliative treatment of hepatocellular carcinoma by chemoembolization. Acta Radiol 2001;42:602-7.
20. Pelletier G, Ducreux M, Gay F, et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial. Groupe CHC. J Hepatol 1998;29:129-34.
21. Bruix J, Llovet JM, Castells A, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution. Hepatology 1998;27:1578-83.
22. Zhang Z, Liu Q, He J, et al. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000;89:2606-12.
23. Gerunda GE, Neri D, Merenda R, et al. Role of transarterial chemoembolization before liver resection for hepatocarcinoma. Liver Transpl 2000;6:619-26.
24. Paye F, Jagot P, Vilgrain V, et al. Preoperative chemoembolization of hepatocellular carcinoma: A comparative study. Arch Surg 1998;133:767-72.
25. Oldhafer KJ, Chavan A, Fruhauf NR, et al. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: Marked tumor necrosis, but no survival benefit? J Hepatol 1998;29:953-9.
26. Yamada R, Kishi K, Sato M, et al. Transcatheter arterial chemoembolization (TACE) in the treatment of unresectable liver cancer. World J Surg 1995;19:795-800.
27. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688-701.
28. Fan J, Yu Y, Wu Z. Liver resection after transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma and curative effect analysis. Zhonghua Wai Ke Za Zhi 1997;35:710-2.
29. Harada T, Matsuo K, Inoue T, et al. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 1996;224:4-9.
30. Li JQ, Zhang YQ, Zhang WZ, et al. Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy. J Cancer Res Clin Oncol 1995;121:364-6.
31. Lin Z, Ren Z, Xia J. Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence. Zhonghua Zhong Liu Za Zhi 2000;22:315-7.
32. Partensky C, Sassolas G, Henry L, et al. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: A phase 2 clinical study. Arch Surg 2000;135:1298-300.
33. Lau WY, Leung TW, Ho SK, et al. Adjuvant intra-arterial iodine 131 labeled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial. Lancet 1999;353:797-801.
34. Takayasu K, Muramatsu Y, Maeda T, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system. AJR Am J Roentgenol 2001;176:681-8.
35. Wu CC, Ho YZ, Ho WL, et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal. Br J Surg 1995;82:122-6.
36. Lu CD, Peng SY, Jiang XC, et al. Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: Retrospective analysis of 120 cases. World J Surg 1999;23:293-300
37. Trevisani F, De Notariis S, Rossi C, et al. Randomized control trials on chemoembolization for hepatocellular carcinoma: Is there room for new studies? J Clin Gastroenterol 2001;32:383-9.
38. Ernst O, Sergent G, Mizrahi D, et al. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: Comparison of planned periodic chemoembolization and chemoembolization based on tumor response. AJR Am J Roentgenol 1999;172:59-64.
39. Gates J. Hartnell GG, Stuart KE, et al. Chemoembolization of hepatic neoplasms: Safety, complications, and when to worry. Radiographics 1999;19:399-414.
40. Tarazov PG, Polysalov VN, Prozorovskij KV, et al. Ischemic complications of transcatheter arterial chemoembolization in liver malignancies. Acta Radiol 2000;41:156-60.
41. Song SY, Chung JW, Han JK, et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: Incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 2001;12:313-20.
42. Kim HK, Chung YH, Song BC, et al. Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 2001;32:423-7.
43. Kim W, Clark TW, Baum RA, et al. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol 2001;12:965-8.
44. Caturelli E, Siena DA, Fusilli S, et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: Evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology 2000;215:123-8.
45. Poon RT, Ngan H, Lo CM, et al. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 2000;73:109-14.
46. Livraghi T, Giorgio A, Marin A. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 1995;197:101-8.
47. Shiina S, Tagawa K, Niwa Y. Percutaneous ethanol injection therapy for hepatocellular carcinoma: Results in 146 patients. AJR Am J Roentgenol 1993;160: 1023-5.
48. Kawano M. An experimental study of percutaneous absolute ethanol injection therapy for small hepatocellular carcinoma: Effects of absolute ethanol on healthy canine liver. Gastroenterol Jpn 1989;24:663-9.
49. Shiina S, Tagawa K, Unuma T. Percutaneous ethanol injection therapy for hepatocellular carcinoma: A histopathologic study. Cancer 1991;68:1524-30.
50. Giovannini M, Seltx UF. Ultrasound guided percutaneous alcohol injection of small liver metastases. Cancer 1994;73:294-7.
51. Livraghi T, Vettori C, Torzilli G, et al. Percutaneous ethanol injection of hepatic tumors: Single-session therapy under general anesthesia. AJR Am J Roentgenol 1993;160:1065-9.
52. Shiina S, Teratani T, Obi S, et al. Nonsurgical treatment of hepatocellular carcinoma: From percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002;62(Suppl 1):64-8.
53. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992;69:925-9.
54. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 1995;197:101-8.
55. Shiina S, Tagawa K, Unuma T, et al. Percutaneous ethanol injection therapy of hepatocellular carcinoma: Analysis of 77 patients. AJR Am J Roentgenol 1990; 155:1221-6.
56. Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: Results in 146 patients. AJR Am J Roentgenol 1993;160:1023-8.
57. Lencioni R, Paolicchi A, Bartolozzi C. [Percutaneous alcohol administration for hepatocarcinoma: Long-term results.] Radiol Med (Torino) 1997;94:8-13.
58. Meloni F, Lazzaroni S, Livraghi T. Percutaneous ethanol injection: Single session treatment. Eur J Ultrasound 2001;13:107-15.
59. Giorgio A, Tarantino L, de Stefano G, et al. Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: Long-term results in 268 patients. Eur J Ultrasound 2000;12:145-54.
60. Pompili M, Rapaccini GL, Covino M, et al. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy. Cancer 2001;92:126-35.
61. Lencioni R, Caramella D, Bartolozzi C. Hepatocellular carcinoma: Use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. Radiology 1995;194:113-8.
62. Toyoda H, Kumuda T, Nakano S, et al. Significance of tumor vascularity as a predictor of long-term prognosis in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection therapy. J Hepatol 1997;26:1055-62.
63. Livraghi T, Benedini V, Lazzaroni S, et al. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998;83:48-57.
64. Dalla Palma L, Pozzi Mucelli R, Sponza M, et al. Diagnostic imaging and interventional therapy in hepatocarcinoma. Multicenter study of 290 cases. Radiol Med (Torino) 1997;94:30-6.
65. Hasegawa S, Yamasaki N, Hiwaki T, et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 1999;86:1682-90.
66. Ryu M, Shimamura Y, Kinoshita T, et al. Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: A retrospective multicenter study. Jpn J Clin Oncol 1997;27:251-7.
67. Bartolozzi C, Lencioni R. Ethanol injection for the treatment of hepatic tumors. Eur Radiol 1996;6:682-96.
68. Becker D, Hansler JM, Strobel D, et al. Percutaneous ethanol injection and radio-frequency ablation for the treatment of nonresectable colorectal liver metastases: Techniques and results. Langenbecks Arch Surg 1999;384:339-43.
69. Livraghi T, Goldberg SN, Meloni F, et al. Hepatocellular carcinoma: Comparison of efficacy between percutaneous ethanol instillation and radiofrequency. Radiology 1999;210:655-63.
70. Ikeda M, Okada S, Ueno H, et al. Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: A comparative study. Jpn J Clin Oncol 2001;31:322-6.
71. Ishii H, Okada S, Nose H, et al. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1996;77:1792-6.
72. Braune C, Widjaja A, Bartels M, et al. Surgical removal of a distinct subcutaneous metastasis of multilocular hepatocellular carcinoma 2 months after initial percutaneous ethanol injection therapy. Z Gastroenterol 2001;39:789-92.
73. Casella G, Cacopardo E, Rovere G, et al. Cutaneous seeding after ultrasound-guided percutaneous ethanol injection for treatment of hepatocellular carcinoma. J Clin Ultrasound 2001;29:354-8.
74. Ishii H, Okada S, Okusaka T, et al. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1998;82:1638-42.
75. Lin SM, Kuo SH, Lin DY, et al. Cytologic changes in hepatocellular carcinoma after percutaneous acetic acid injection. Correlation with helical computed tomography findings. Acta Cytol 2000;44:1-6.
76. Ohnishi K, Ohyama N, Ito S, et al. Small hepatocellular carcinoma: Treatment with US-guided intratumoral injection of acetic acid. Radiology 1994;193:747-52.
77. Ohnishi K, Yoshioka H, Kosaka K, et al. Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: Comparison with segmental transcatheter arterial embolization. Am J Gastroenterol 1996;91:2574-9.
78. Ohnishi K, Yoshioka H, Ito S, et al. Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. Hepatology 1996;24:1379-85.
79. Ohnishi K, Nomura F, Ito S, et al. Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: Study of 91 cases. Hepatology 1996;23:994-1002.
80. Ohnishi K, Yoshioka H, Ito S, et al. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998;27:67-72.
81. Dupuy D, Goldberg S. Image-guided radiofrequency tumor ablation: Challenges and opportunities - Part II. J Vasc Interv Radiol 2001;12:1135-48.
82. Livraghi T, Lazzaroni S, Meloni F. Radiofrequency thermal ablation of hepatocellular carcinoma. Eur J Ultrasound 2001;13:159-66.
83. Cosman E, Nashold B, Ovelman-Levitt J. Theoretical aspects of radiofrequency lesions in the dorsal root entry zone. Neurosurgery 1984;15:945-50.
84. Goldberg SN, Stein M, Gazelle GS, et al. Percutaneous radiofrequency tissue ablation: Optimization of pulsed-RF technique to increase coagulation necrosis. J Vasc Interv Radiol 1999;10:907-16.
85. Goldberg SN, Gazelle GS, Solbiati L, et al. Radiofrequency tissue ablation: Increased lesion diameter with a perfusion electrode. Acad Radiol 1996;3:636-44.
86. Curley SA, Izzo F, Delrio P. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients. Ann Surg 1999; 230:1-8.
87. Livraghi T, Meloni F, Goldberg SN, et al. Hepatocellular carcinoma: Radiofrequency ablation of medium and large lesions. Radiology 2000;214:761-8.
88. Rossi S, DiStasi M, Buscarini E. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996;167:759-68.
89. Rossi S, Buscarini E, Garbagnati F. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998;170:1015-22.
90. Buscarini L, Buscarini E, Di Stasi M, et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: Long-term results. Eur Radiol 2001;11:914-21.
91. Matsunami H, Shimizu Y, Lynch SV, et al. Liver transplantation as a therapeutic option for hepatocellular carcinoma. Oncology 2002;62(Suppl 1):82-6.
92. Teo EK, Fock KM. Hepatocellular carcinoma: An Asian perspective. Dig Dis 2001;19:263-8.
93. Siperstein A, Garland A, Engle K, et al. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol 2000;7:106-13.
94. Gazelle GS, Goldberg SN, Solbiati L, et al. Tumor ablation with radiofrequency energy. Radiology 2000;217:6333-46.
95. Buscarini L, Buscarini E, Di Stasi M, et al. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med 1999;20:47-53.
96. Aschoff AJ, Merkle EM, Wong V, et al. How does alteration of hepatic blood flow affect liver perfusion and radiofrequency-induced thermal lesion size in rabbit liver? J Magn Reson Imaging 2001;13:57-63.
97. de Baere T, Bessoud B, Dromain C, et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol 2002;178:53-9.
98. Goldberg SN, Ahmed M, Gazelle GS, et al. Radiofrequency thermal ablation with adjuvant saline injection: Effect of electrical conductivity on tissue heating and coagulation. Radiology 2001;219:157-65.
99. Livraghi T, Goldberg SN, Monti F, et al. Saline-enhanced radiofrequency tissue ablation in the treatment of liver metastases. Radiology 1997;202:205-10.
100. Miao Y, Ni Y, Yu J, et al. A comparative study on validation of a novel cooled-wet electrode for radiofrequency liver ablation. Invest Radiol 2000;35:438-44.
101. Miao Y, Ni Y, Yu J, et al. An ex vivo study on radiofrequency tissue ablation: Increased lesion size by using an "expandable-wet" electrode. Eur Radiol 2001;11:1841-7.
102. Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381-91.
103. Goldberg SN, Solbiati L, Halpern EF, et al. Variables affecting proper system grounding for radiofrequency ablation in an animal model. J Vasc Interv Radiol 2000;11:1069-75.
104. Livraghi T, Solbiati L, Meloni F, et al. Complications after cool-tip RF ablation of liver cancer: Initial report of the Italian Multicenter Cool-tip RF Study Group. Radiology 2000;217(P):18.
105. de Sio I, Castellano L, De Girolamo V, et al. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:609-10.
106. Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124-9.
107. Goldberg SN, Solbiati L. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:609.
108. Livraghi T. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:608-9.
109. King RWP, Shen LC, Wu TT. Embedded insulated antenna for communication and heating. Electromagnetics 1981;1:51-72.
110. Foster KR, Schepps JL. Dielectric properties of tumor and normal tissues at radio through microwave frequencies. J Microwave Power 1981;16:107-19.
111. Moriyama E, Matsumi N, Shiraishi T, et al. Hyperthermia for brain tumors: Improved delivery with a new cooling system. Neurosurgery 1988;23:189-95.
112. Saitsu H, Mada Y, Taniwaki S, et al. Investigation of microwave coagulonecrotic therapy for 21 patients with small hepatocellular carcinoma less than 5 cm in diameter. Nippon Geka Gakkai Zasshi 1993;94:356-65.
113. Saitsu H, Nakayama T. Microwave coagulo-necrotic therapy for hepatocellular carcinoma. Nippon Rinsho 1993;51:1102-7.
114. Watanabe Y, Sato M, Abe Y, et al. Laparoscopic microwave coagulo-necrotic therapy for hepatocellular carcinoma: A feasible study of an alternative option for poor-risk patients. J Laparoendosc Surg 1995;5:169-75.
115. Sato M, Watanabe Y, Ueda S, et al. Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology 1996;110:1507-14.
116. Beppu T, Ogawa M, Matsuda T, et al. Efficacy of microwave coagulation therapy (MCT) in patients with liver tumors. Gan To Kagaku Ryoho 1998;25:1358-61.
117. Dong BW, Liang P, Yu XL, et al. Sonographically guided microwave coagulation treatment of liver cancer: An experimental and clinical study. AJR Am J Roentgenol 1998;171:449-54.
118. Lu MD, Chen JW, Xie XY, et al. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001;221:167-72.
119. Seki T, Wakabayashi M, Nakagawa T, et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: Comparison with percutaneous ethanol injection therapy. Cancer 1999;85:1694-702.
120. Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994;74:817-25.
121. Itamoto T, Asahara T, Kohashi T, et al. Percutaneous microwave coagulation therapy for hepatocellular carcinoma. Gan To Kagaku Ryoho 1999;26:1841-4.
122. Hamazoe R, Hirooka Y, Ohtani S, et al. Intraoperative microwave tissue coagulation as treatment of patients with nonresectable hepatocellular carcinoma. Cancer 1995;75:794-800.
123. Hamazoe R, Takahashi S, Sumi K, et al. Intraoperative interstitial microwave therapy for recurrent hepatocellular carcinoma of the caudate lobe: A case report. Gan To Kagaku Ryoho 1997;24:1735-7.
124. Shibata T, Takami M, Fujimoto T, et al. An attempt at intraoperative, ultra-sound-guided microwave tissue coagulation for metastatic liver tumors. Gan To Kagaku Ryoho 1992;19:1605-8.
125. Ido K, Isoda N, Kawamoto C, et al. Laparoscopic microwave coagulation therapy for solitary hepatocellular carcinoma performed under laparoscopic ultrasonography. Gastrointest Endosc 1997;45:415-20.
126. Ido K, Isoda N, Sugano K. Microwave coagulation therapy for liver cancer: Laparoscopic microwave coagulation. J Gastroenterol 2001;36:145-52.
127. Seki S, Sakaguchi H, Kadoya H, et al. Laparoscopic microwave coagulation therapy for hepatocellular carcinoma. Endoscopy 2000;32:591-7.
128. Asahara T, Katayama K, Itamoto T, et al. Thoracoscopic microwave coagulation therapy for hepatocellular carcinoma. Hiroshima J Med Sci 1998;47:125-31.
129. Asahara T, Nakahara H, Fukuda T, et al. Percutaneous microwave coagulation therapy for hepatocellular carcinoma. Hiroshima J Med Sci 1998;47:151-5.
130. Horigome H, Nomura T, Saso K, et al. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: Consideration of local recurrence. Am J Gastroenterol 1999;94:1914-7.
131. Matsukawa T, Yamashita Y, Arakawa A, et al. Percutaneous microwave coagulation therapy in liver tumors. A 3-year experience. Acta Radiol 1997;38:410-5.
132. Ohmoto K, Miyake I, Tsuduki M, et al. Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology 1999;46:2894-900.
133. Ohmoto K, Tsuzuki M, Yamamoto S. Percutaneous microwave coagulation therapy with intraperitoneal saline infusion for hepatocellular carcinoma in the hepatic dome. AJR Am J Roentgenol 1999;172:65-6.
134. Kato T, Tamura S, Tekin A, et al. Use of microwave coagulation therapy in liver transplant candidates with hepatocellular carcinoma: A preliminary report. Transplant Proc 2001;33:1469.
135. Hiraki M, Kurohiji T, Kimitsuki H, et al. Influence of liver function on stereotactic microwave tissue coagulation therapy for hepatocellular carcinoma. Gan To Kagaku Ryoho 1994;21:2215-7.
136. Ryan TP. Comparison of six microwave antennas for hyperthermia treatment of cancer: SAR results for single antennas and arrays. Int J Rad Onc Biol Phy 1991;21:403-13.
137. Sato M, Watanabe Y, Kashu Y, et al. Sequential percutaneous microwave coagulation therapy for liver tumor. Am J Surg 1998;175:322-4.
138. Murakami T, Shibata T, Ishida T, et al. Microwave hepatic tumor coagulation therapy during stoppage of hepatic blood flow using balloon catheters. Nippon Igaku Hoshasen Gakkai Zasshi 1998;58:369-71.
139. Murakami T, Shibata T, Ishida T, et al. Percutaneous microwave hepatic tumor coagulation with segmental hepatic blood flow occlusion in seven patients. AJR Am J Roentgenol 1999;172:637-40.
140. Shibata T, Takami M, Tsujinaka T, et al. Study on therapeutics adopted after occlusion of intraarterial reservoir in patients with liver tumor. Gan To Kagaku Ryoho 1995;22:1464-8.
141. Shimada S, Hirota M, Beppu T, et al. Complications and management of microwave coagulation therapy for primary and metastatic liver tumors. Surg Today 1998;28:1130-7.
142. Brown S, Laser-tissue interactions. In: Krasner N, ed. Lasers in Gastroenterology. London: Chapman & Hall Medical, 1991:37-50.
143. Dachman AH, McGehee JA, Beam TE, et al. US-guided percutaneous laser ablation of liver tissue in a chronic pig model. Radiology 1990;176:129-33.
144. Jiao LR, Hansen PD, Havlik R, et al. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg 1999;177: 303-6.
145. Nolsoe CP, Torp-Pedersen S, Burcharth F, et al. Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: A pilot clinical study. Radiology 1993;187:333-7.
146. Diederich CJ, Nau WH, Deardorff DL. Prostate thermal therapy with interstitial and transurethral ultrasound applicators: A feasibility study. In: Thomas P. Ryan, ed. Surgical Applications of Energy, Proceedings of SPIE. Vol. 3249. 1998:2-13.
147. Vogl TJ, Muller PK, Hammerstingl R, et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: Technique and prospective results. Radiology 1995;196:257-65.
148. Tranberg KG, Moller PH, Hannesson P, et al. Interstitial laser treatment of malignant tumors: Initial experience. Eur J Surg Oncol 1996;22:47-54.
149. Christophi C, Muralidharan V. Treatment of hepatocellular carcinoma by percutaneous laser hyperthermia. J Gastroenterol Hepatol 2001;16:548-52.
150. Eichler K, Mack MG, Straub R, et al. Oligonodular hepatocellular carcinoma (HCC): MR-controlled laser-induced thermotherapy. Radiologe 2001;41:915-22.
151. Vogl TJ, Mack M, Straub R, et al. Percutaneous interstitial thermotherapy of malignant liver tumors. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2000;172:12-22.
152. Yu YQ. High-power nd:yag laser in the treatment of liver cancer: Experimental study and clinical application. In: Tang ZY, ed. Subclinical Hepatocellular Carcinoma. New York: Springer-Verlag, 1984:120-3.
153. Fleisher D. Endoscopic laser therapy for gastrointestinal neoplasms. Surg Clin North Am 1984;61:947-53.
154. Thomsen S. Pathologic analysis of photothermal and photomechanical effects of laser tissue interactions. Photochem Photobiol 1991;53:825-35.
155. Nolsoe CP, Torp-Pedersen S, Holm HH, et al. Ultrasonically guided interstitial Nd-YAG laser diffuser tip hyperthermia: An in vitro study. Scand J Urol Nephrol Suppl 1991;137:119-24.
156. Amin Z, Donald JJ, Masters A. Hepatic metastases: Interstitial laser photocoagulation with real-time US monitoring and dynamic CT evaluation of treatment. Radiology 1993;187:339-47.
157. Moller PH, Hannesson PH, Ivarsson K, et al. Interstitial laser thermotherapy in pig liver: Effect of inflow occlusion on extent of necrosis and ultrasound image. Hepatogastroenterology 1997;44:1302-11.
158. Sturesson C, Liu DL, Stenram U, et al. Hepatic inflow occlusion increases the efficacy of interstitial laser-induced thermotherapy in rat. J Surg Res 1997;71: 67-72.
159. Muralidharan V, Christophi C. Interstitial laser thermotherapy in the treatment of colorectal liver metastases. J Surg Oncol 2001;76:73-81.
160. Mack MG, Straub R, Eichler K, et al. Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases. Abdom Imaging 2001;26:369-74.
161. Schroder T, Castren-Persons M, Lehtinen A, et al. Percutaneous interstitial laser hyperthermia in clinical use. Ann Chir Gynaecol 1994;83:286-90.
162. Moroz P, Jones SK, Gray BN. Status of hyperthermia in the treatment of advanced liver cancer. J Surg Oncol 2001;77:259-69.
163. Beppu T, Ishiko T, Doi K, et al. [A promising new treatment strategy for advanced hepatocellular carcinoma: "Multi-ablation therapy" consisting of radio-frequency ablation (RFA), microwave coagulation therapy (MCT) and ethanol injection therapy (EIT).] Gan To Kagaku Ryoho 2001;28:1583-6.
164. Goldberg SN, Kruskal JB, Oliver BS, et al. Percutaneous tumor ablation: Increased coagulation by combining radiofrequency ablation and ethanol instillation in a rat breast tumor model. Radiology 2000;217:827-31.
165. Allgaier HP, Deibert P, Olschewski M, et al. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection: A single-center analysis including 132 patients. Int J Cancer 1998;79:601-5.
166. Bartolozzi C, Lencioni R, Armillotta N. Combined treatment of hepatocarcinoma with chemoembolization and alcohol administration. Long-term results. Radiol Med (Torino) 1997;94:19-23.
167. Ishii H, Okada S, Sato T, et al. Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization. Hepatogastroenterology 1996;43:644-50.
168. Dohmen K, Shirahama M, Shigematsu H, et al. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: An evaluation of the local therapeutic effect and survival rate. Hepatogastroenterology 2001;48:1409-15.
169. Koda M, Murawaki Y, Mitsuda A, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: A randomized control study. Cancer 2001;92:1516-24.
170. Tanaka K, Nakamura S, Numata K, et al. Hepatocellular carcinoma: Treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 1992;185:457-60.
171. Lencioni R, Cioni D, Donati F, et al. Combination of interventional therapies in hepatocellular carcinoma. Hepatogastroenterology 2001;48:8-14.
172. Seki T, Tamai T, Nakagawa T, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000;89:1245-51.
173. Goldberg SN, Saldinger PF, Gazelle GS, et al. Percutaneous tumor ablation: Increased coagulation necrosis with combined radiofrequency and percutaneous doxorubicin injection. Radiology 2001;220:420-7.
174. Goldberg SN, Kamel IR, Kruskal JB, et al. Radiofrequency ablation of hepatic tumors: Increased tumor destruction with adjuvant liposomal doxorubicin therapy. AJR Am J Roentgenol 2002;179:93-101.
175. Monsky WE, Kruskal JB, Lukyanov AN, et al. Radiofrequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Radiology 2002;224:823-9.